Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001105BKPyvENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TVIS46001309BKPyvENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TVIS30003065HIVENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TVIS30003066HIVENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TVIS30014350HIVENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TVIS20002530HPVENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TVIS20015438HPVENSG00000079385.23protein_codingCEACAM1NoNo634P13688
Q3KRG8
TCGA Plot Options
Drug Information
GeneCEACAM1
DrugBank IDDB00113
Drug NameTechnetium Tc-99m arcitumomab
Target IDBE0000107
UniProt IDP13688
Regulation Typeother/unknown
PubMed IDs12865871; 9389396
CitationsFuster D, Maurel J, Muxi A, Setoain X, Ayuso C, Martin F, Ortega ML, Fuertes S, Pons F: Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Q J Nucl Med. 2003 Jun;47(2):109-15.@@Hughes K, Pinsky CM, Petrelli NJ, Moffat FL, Patt YZ, Hammershaimb L, Goldenberg DM: Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surg. 1997 Nov;226(5):621-31.
GroupsExperimental
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164746540
ChEMBLCHEMBL2108253